A study on FUO in Guinea found diverse bacterial and viral infections, frequent misdiagnoses, and high antibiotic resistance, ...

LA JOLLA, CA—New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human ...

Broad-Spectrum Antiviral NV-387 Phase II Clinical Trial Responding to MPox Pandemic in Africa, Readying to Tackle Bird Flu ...

Influenza A Viruses Adapt Shape in Response to Environmental Pressures Feb. 10, 2025 — Influenza A virus particles strategically adapt their shape -- to become either spheres or larger filaments ...

KAMPALA, Uganda — Ebola cases in Uganda have risen to nine, while 265 other people were being monitored under quarantine, ...

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...

In an unprecedented move, Uganda's rapid launch of an Ebola vaccine trial is not only a significant scientific milestone, but also a bold statement that the world can no longer afford to wait for ...

There are no approved vaccines or treatments for Sudan virus disease, which has a 40–70% fatality rate. To curb the ongoing outbreak, Uganda has deployed—under a clinical trial setting—a vaccine ...

Determining the species that are more likely to host such viruses can help identify potential areas in danger and prevent ...

U.S. health officials on Wednesday urged Americans traveling to Uganda to take precautions because of an Ebola outbreak — and said they are helping Ugandan health officials respond to the threat ...

An emergency vaccine trial has been launched to combat a new outbreak of the deadly Sudan strain of Ebola virus. The World Health Organisation (WHO) said the trial in Uganda had been established with ...

Ugandan doctors liaise with the contact of a patient who tested positive for Ebola Credit ... the past been difficult to organise because the virus flares up, often in remote areas, before ...